this combined form is investigational and not FDA-approved
With regards to symptom improvement, while there was a substantial reduction in IBS-SSS (as well as GSRS sub scores for diarrhea, bloating and pain), change in IBS-SSS was not correlated with changes in GLP-1
People with a history of pancreatitis, severe gastrointestinal disease, or diabetic retinopathy may need an alternative approach
Lower is usually better
Along with Novo Nordisk's Wegovy, Eli Lilly's weight-loss pill, orforglipron, will be sold for $149 for the lowest dose, Eli Lilly said in a statement
Inulin, fructooligosaccharides (FOS), galactooligosaccharides (GOS), and resistant starch all fall into this category